Company Filing History:
Years Active: 2014
Title: Innovations by Zhongting Xia in Diabetes Treatment
Introduction
Zhongting Xia is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative approach combines traditional herbal medicine with modern pharmaceutical techniques.
Latest Patents
Zhongting Xia holds a patent for a pharmaceutical composition aimed at treating diabetes mellitus. The patent, titled "Pharmaceutical composition for treating diabetes and its process for preparation," outlines methods for preparing a composition that includes various herbal extracts. The composition consists of 5-40 weight parts of Tianhuafen, 10-30 weight parts of Chaihu, 3-15 weight parts of Zhishi, 1-6 weight parts of Dahuang, 1-12 weight parts of Banxia, 3-15 weight parts of Huangqin, 1-12 weight parts of Huanglian, 3-15 weight parts of Baishao, and 5-20 weight parts of Wumei. Additionally, it may include Shanzha and pharmaceutically acceptable excipients. The invention also discloses four methods for preparing this pharmaceutical composition.
Career Highlights
Zhongting Xia is associated with Tasly Pharmaceutical Group Co., Ltd., a company known for its focus on traditional Chinese medicine and modern pharmaceutical innovations. His work at Tasly has allowed him to explore the intersection of herbal remedies and contemporary medical practices.
Collaborations
Zhongting Xia has collaborated with notable colleagues, including Xiaolin Tong and Yonghong Zhu. Their combined expertise contributes to the advancement of pharmaceutical research and development within their organization.
Conclusion
Zhongting Xia's innovative work in developing a pharmaceutical composition for diabetes treatment showcases the potential of integrating traditional medicine with modern science. His contributions are significant in the ongoing fight against diabetes, highlighting the importance of innovation in healthcare.